TEXAS-DEVELOPED PATENT-FREE COVID-19 VACCINE TECHNOLOGY RECEIVES EMERGENCY USE AUTHORIZATION IN INDONESIA
Retrieved on:
Friday, September 30, 2022
Certification, Bio Farma, Health, Baylor, HMO, COVID-19, Tropical medicine, Twitter, Jan, KAEF, Hospital, Pediatrics, Texas Children's Hospital, Kings County Hospital Center, View, News, Halal certification in the Philippines, Baylor University, Partnership HealthPlan of California, Vaccine, Baylor College of Medicine, INAF, Research, Pharmacy, National school, CVD, Multimedia, Urgent care center, Education, Pharmaceutical industry, Woman
Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
Key Points:
- Itreceived emergency use authorization in Indonesia, as a primary vaccine in adults.
- Indonesia is seeking Halal Certification for the vaccine since no animal cells or products were used in the production of the vaccine.
- The pharmaceutical company is currently manufacturing Covid-19 primary series vaccine, while booster vaccine is in the clinical trial stage and soon followed by vaccine for children.
- Bio Farma became a holding company after a merger of three listed state-owned pharmaceutical companies in Indonesia.